top of page

3. Quick and accurate sequencing

Utilizing our accumulated technology and algorithms, the COPAS and MALDI-TOF/MS analysis devices facilitate swift and precise sequencing of substantial candidate

materials, setting us apart from competitors in terms of efficiency and accuracy.

2. High selectivity and excellent binding

By refining the Bead-Peptide coupling during the peptide library synthesis phase and incorporating zwitterionic dye, our technology enables precise peptide screening

for target proteins, surpassing conventional methodologies in specificity and affinity sequencing.

1. High blood stability

By incorporating unnatural amino acids during the initial library construction stage, we can synthesize peptides that exhibit exceptional stability in the bloodstream.

Our innovative discovery platform, CUS™, facilitates the identification of peptides with remarkable stability and selectivity through a three-differentiated approach:

(1) Crafting a high-purity library using an optimized process, (2) Employing a novel screening procedure that minimizes background interactions, and

(3) Achieving direct sequencing utilizing our proprietary analyzing algorithm.


Peptide Discovery Platform CUS™

Points of differentiation (CUS™  Platform)


No posts published in this language yet
Once posts are published, you’ll see them here.

Directing GDNF-mediated neuronal signaling with proactively programmable cell-surface saccharide-free glycosaminoglycan mimetics

Chemical Communication


Facile saccharide-free mimetics that recapitulate key features of glycosaminoglycan sulfation Patterns

Chemical Science


combinatorial Bead-Based Peptide Libraries Improved For Rapid and Robust Screenings

Current Topics in Medicinal Chemistry


An Efficient Strategy to Enhance Binding Affinity and Specificity of a Known Isozyme Inhibitor

Organic & Biomolecular Chemistry


Self-Assembling Peptide Nanofibrous Hydrogel as a Versatile Drug Delivery Platform

Current Pharmaceutical Design


Enzymatic conjugation of a bioactive peptide into an injectable hyaluronic acid–tyramine hydrogel system to promote the formation of functional vasculature

Acta Biomaterialia


Investigating Fluorescent Dyes in Fluorescence Assisted Screenings

Chemical Communications


In Situ Click Chemistry: from Small Molecular Discovery to Synthetic Antibodies

Integrative Biology


Process Automation toward Ultra-High Throughput Screening of Combinatorial One-Bead-One-Compound(OBOC) Peptide Libraries

Journal of Laboratory Automation


Iterative in Situ Click Chemistry Assembles a Branched Capture Agent and Allosteric Inhibitor for AKT1

Journal of The American Chemistry Society


Accurate MALDI-TOF/TOF Sequencing of One-Bead-One-Compound Peptide Libraries with Application to the Identification of Multiligand Protein Affinity Agents Using In Situ Click Chemistry Screening

Analytical Chemistry


Rapid Microwave-Assisted CNBr Cleavage of Bead-Bound Peptides

Journal of Combinatorial Chemistry







C-Biomex is seeking strategies to diversify new drug development for developing innovative treatments through continuous cooperative research with domestic and foreign companies and professional research institutes.

R&D/Industry: Trioar, Eflask, Portrai, Pohang Pohang Techno Park

R&D/Academy: Seoul National University, JHU, Korea Institute of radiological & medical sciences


Theragnostic represents a dual-purpose strategy involving both cancer diagnosis and treatment, utilizing radiotracers. Radiotracers are composed of radiation and chemicals that specifically attach to a particular target within the body. Achieving this entails accurate targeting of radioactive isotopes to the tumor while ensuring rapid elimination to minimize any potential toxicity.

Discovery & Development of Radio Ligand Theragnostic

1. Differential advantages of C-biomex radio ligand theranostics: excellent PK Profile

2. Strong targeting for cancer and minimizing toxicity through fast clearance (Hit Hard Leave Fast)

Points of differentiation (CUS™  Platform)

bottom of page